Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA
Open accessThe DOI matches its Crossref record.
Abstract
Tumor-associated peptide-human leukocyte antigen complexes (pHLAs) represent the largest pool of cell surface-expressed cancer-specific epitopes, making them attractive targets for cancer therapies. Soluble bispecific molecules that incorporate an anti-CD3 effector function are being developed to redirect T cells against these targets using 2 different approaches. The first achieves pHLA recognition via affinity-enhanced versions of natural TCRs (e.g., immune-mobilizing monoclonal T cell receptors against cancer [ImmTAC] molecules), whereas the second harnesses an antibody-based format (TCR-mimic antibodies). For both classes of reagent, target specificity is vital, considering the vast universe of potential pHLA molecules that can be presented on healthy cells. Here, we made use of structural, biochemical, and computational approaches to investigate the molecular rules underpinning the reactivity patterns of pHLA-targeting bispecifics. We demonstrate that affinity-enhanced TCRs engage pHLA using a comparatively broad and balanced energetic footprint, with interactions distributed over several HLA and peptide side chains. As ImmTAC molecules, these TCRs also retained a greater degree of pHLA selectivity, with less off-target activity in cellular assays. Conversely, TCR-mimic antibodies tended to exhibit binding modes focused more toward hot spots on the HLA surface and exhibited a greater degree of crossreactivity. Our findings extend our understanding of the basic principles that underpin pHLA selectivity and exemplify a number of molecular approaches that can be used to probe the specificity of pHLA-targeting molecules, aiding the development of future reagents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Taylor, B. C., & Balko, J. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844866 · Cited by 298
Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies
Kroll, K. T., Mata, M. M., Homan, K. A., Micallef, V., Carpy, A., Hiratsuka, K., Morizane, R., Moisan, A., Gubler, M., Walz, A.-C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305322120 · Cited by 79
Mahoney, K. E., Reser, L., Ruiz Cuevas, M. V., Abelin, J. G., Shabanowitz, J., Hunt, D. F., & Malaker, S. A. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100971 · Cited by 9
Multi-strategy embedded framework for neoantigen vaccine maturation
(2026) · doi:10.1038/s41598-025-34618-8 · Cited by 4
Metadata
- Authors
- Holland, C. J., Crean, R. M., Pentier, J. M., de Wet, B., Lloyd, A., Srikannathasan, V., Lissin, N., Lloyd, K. A., Blicher, T. H., Conroy, P. J., Hock, M., Pengelly, R. J., Spinner, T. E., Cameron, B., Potter, E. A., Jeyanthan, A., Molloy, P. E., Sami, M., Aleksic, M., Liddy, N., Robinson, R. A., Harper, S., Lepore, M., Pudney, C. R., van der Kamp, M. W., Rizkallah, P. J., Jakobsen, B. K., Vuidepot, A., & Cole, D. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2020-04-20
- Volume
- 130
- Issue
- 5
- Pages
- 2673-2688
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W3017309521
- Cited by
- 90
- References
- 0
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA. https://app.cochat.ai/papers/10.1172/jci130562
- The paper
- Holland, C. J., Crean, R. M., Pentier, J. M., de Wet, B., Lloyd, A., Srikannathasan, V., Lissin, N., Lloyd, K. A., Blicher, T. H., Conroy, P. J., Hock, M., Pengelly, R. J., Spinner, T. E., Cameron, B., Potter, E. A., Jeyanthan, A., Molloy, P. E., Sami, M., Aleksic, M., . . . Cole, D. K. (2020). Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA. Journal of Clinical Investigation. https://doi.org/10.1172/jci130562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.